Cholesterol-containing compounds and their use as immunogens against Borrelia burgdorferi

Details for Australian Patent Application No. 2004228631 (hide)

International Classifications

Event Publications

27 October 2005 PCT application entered the National Phase

PCT publication WO2004/089969 Priority application(s): WO2004/089969

17 November 2005 Amendment Made

The nature of the amendment is: Amend the name of the applicant from The Government of the United States of America as represented by The Secretary, Department of Healthand Human Services to The Government of the United States of America as represented by The Secretary, Department of Health and Human Services

2 December 2010 Application Accepted

Published as AU-B-2004228631

31 March 2011 Standard Patent Sealed

25 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.